Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-005694
Filing Date
2025-04-28
Accepted
2025-04-28 16:32:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A xlo-20250428xdefa14a.htm DEFA14A 13809
2 GRAPHIC xlo-20250428xdefa14a_bg001.jpg GRAPHIC 159538
3 GRAPHIC xlo-20250428xdefa14a_bg002.jpg GRAPHIC 129624
  Complete submission text file 0001558370-25-005694.txt   413381
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40925 | Film No.: 25880894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)